Ernexa Therapeutics Inc. Gain (Loss) on Disposition of Assets
Ernexa Therapeutics Inc. (ERNA) reported Gain (Loss) on Disposition of Assets of $2.00 thousand for the 6-month period ending 2024-06-30, per its 10-Q filed 2024-08-13.
Financial Statements › Income Statement › Other Income
us-gaap:GainLossOnDispositionOfAssets1 · last filed 2025-03-12
- Ernexa Therapeutics Inc. gain (loss) on disposition of assets for the quarter ending 2023-12-31 was $0.00.
- Ernexa Therapeutics Inc. gain (loss) on disposition of assets for the quarter ending 2023-09-30 was $0.00.
- Ernexa Therapeutics Inc. gain (loss) on disposition of assets for the quarter ending 2022-12-31 was $0.00.
- Ernexa Therapeutics Inc. gain (loss) on disposition of assets for the quarter ending 2022-09-30 was $0.00.
- Ernexa Therapeutics Inc. gain (loss) on disposition of assets for fiscal 2023 was -$1.00K.
- Ernexa Therapeutics Inc. gain (loss) on disposition of assets for fiscal 2022 was $0.00.
- Ernexa Therapeutics Inc. gain (loss) on disposition of assets for fiscal 2021 was -$9.65M.
- Ernexa Therapeutics Inc. gain (loss) on disposition of assets for fiscal 2020 was $0.00.
| Period end | Gain (Loss) on Disposition of Assets 3 month | Gain (Loss) on Disposition of Assets 3 month as first filed | Gain (Loss) on Disposition of Assets 6 month | Gain (Loss) on Disposition of Assets 6 month as first filed | Gain (Loss) on Disposition of Assets 9 month | Gain (Loss) on Disposition of Assets 9 month as first filed | Gain (Loss) on Disposition of Assets 12 month |
|---|---|---|---|---|---|---|---|
| 2024-06-30 | $2.00K 10-Q · filed 2024-08-13 | ||||||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-12 | $0.00 derived: sum of 2 quarters · filed 2025-03-12 | -$1.00K 10-K · filed 2025-03-12 | ||||
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$1.00K 10-Q · filed 2024-11-12 | |||||
| 2023-06-30 | -$1.00K 10-Q · filed 2024-08-13 | ||||||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-20 | $0.00 derived: sum of 2 quarters · filed 2023-03-20 | $0.00 derived: sum of 3 quarters · filed 2023-03-20 | $0.00 10-K · filed 2023-03-20 | |||
| 2022-09-30 | $0.00 10-Q · filed 2022-11-14 | $0.00 derived: sum of 2 quarters · filed 2022-11-14 | $0.00 10-Q · filed 2022-11-14 | $0.00 derived: sum of 4 quarters · filed 2023-03-20 | |||
| 2022-06-30 | $0.00 10-Q · filed 2022-08-11 | $0.00 10-Q · filed 2022-08-11 | $0.00 derived: sum of 3 quarters · filed 2023-03-20 | $0.00 derived: sum of 4 quarters · filed 2023-03-20 | |||
| 2022-03-31 | $0.00 10-Q · filed 2022-07-01 | $0.00 derived: sum of 2 quarters · filed 2023-03-20 | $0.00 derived: sum of 3 quarters · filed 2023-03-20 | -$50.00K derived: sum of 4 quarters · filed 2023-03-20 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-20 | $0.00 derived: sum of 2 quarters · filed 2023-03-20 | -$50.00K derived: sum of 3 quarters · filed 2023-03-20 | -$9.65M 10-K · filed 2023-03-20 | |||
| 2021-09-30 | $0.00 10-Q · filed 2022-11-14 | -$50.00K derived: sum of 2 quarters · filed 2022-11-14 | -$9.65M 10-Q · filed 2022-11-14 | -$9.65M 10-Q · filed 2021-11-12 | -$9.65M derived: sum of 4 quarters · filed 2022-11-14 | ||
| 2021-06-30 | -$50.00K 10-Q · filed 2022-08-11 | -$9.65M 10-Q · filed 2022-08-11 | -$9.65M 10-Q · filed 2021-08-13 | -$9.65M derived: sum of 3 quarters · filed 2022-08-11 | -$9.65M derived: sum of 4 quarters · filed 2022-08-11 | ||
| 2021-03-31 | -$9.60M 10-Q · filed 2022-07-01 | -$9.60M 10-Q · filed 2021-05-17 | -$9.60M derived: sum of 2 quarters · filed 2022-07-01 | -$9.60M derived: sum of 3 quarters · filed 2022-07-01 | -$9.60M derived: sum of 4 quarters · filed 2022-07-01 | ||
| 2020-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2022-07-01 | $0.00 derived: sum of 2 quarters · filed 2022-07-01 | $0.00 derived: sum of 3 quarters · filed 2022-07-01 | $0.00 10-K/A · filed 2022-07-01 | |||
| 2020-09-30 | $0.00 10-Q · filed 2021-11-12 | $0.00 derived: sum of 2 quarters · filed 2021-11-12 | $0.00 10-Q · filed 2021-11-12 | ||||
| 2020-06-30 | $0.00 10-Q · filed 2021-08-13 | $0.00 10-Q · filed 2021-08-13 | |||||
| 2020-03-31 | $0.00 10-Q · filed 2021-05-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |